These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19707043)

  • 1. Use of excised human skin to assess the bioequivalence of topical products.
    Franz TJ; Lehman PA; Raney SG
    Skin Pharmacol Physiol; 2009; 22(5):276-86. PubMed ID: 19707043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products.
    Raney SG; Franz TJ; Lehman PA; Lionberger R; Chen ML
    Clin Pharmacokinet; 2015 Nov; 54(11):1095-106. PubMed ID: 26063051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced absorption through damaged skin: an overview of the in vitro human model.
    Gattu S; Maibach HI
    Skin Pharmacol Physiol; 2010; 23(4):171-6. PubMed ID: 20185974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.
    Leal LB; Cordery SF; Delgado-Charro MB; Bunge AL; Guy RH
    Pharm Res; 2017 Apr; 34(4):730-737. PubMed ID: 28097506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modest but increased penetration through damaged skin: an overview of the in vivo human model.
    Gattu S; Maibach HI
    Skin Pharmacol Physiol; 2011; 24(1):2-9. PubMed ID: 20588085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence assessment of topical clobetasol propionate products using visual and chromametric assessment of skin blanching.
    Au WL; Skinner M; Kanfer I
    J Pharm Pharm Sci; 2008; 11(1):160-6. PubMed ID: 18445371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous Pharmacokinetics of Acyclovir Cream 5% Products: Evaluating Bioequivalence with an In Vitro Permeation Test and an Adaptation of Scaled Average Bioequivalence.
    Shin SH; Rantou E; Raney SG; Ghosh P; Hassan H; Stinchcomb A
    Pharm Res; 2020 Oct; 37(10):210. PubMed ID: 33001286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing topical bioavailability and bioequivalence: a comparison of the in vitro permeation test and the vasoconstrictor assay.
    Lehman PA; Franz TJ
    Pharm Res; 2014 Dec; 31(12):3529-37. PubMed ID: 25005736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stratum Corneum Sampling to Assess Bioequivalence between Topical Acyclovir Products.
    Pensado A; Chiu WS; Cordery SF; Rantou E; Bunge AL; Delgado-Charro MB; Guy RH
    Pharm Res; 2019 Nov; 36(12):180. PubMed ID: 31728737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current challenges in bioequivalence, quality, and novel assessment technologies for topical products.
    Yacobi A; Shah VP; Bashaw ED; Benfeldt E; Davit B; Ganes D; Ghosh T; Kanfer I; Kasting GB; Katz L; Lionberger R; Lu GW; Maibach HI; Pershing LK; Rackley RJ; Raw A; Shukla CG; Thakker K; Wagner N; Zovko E; Lane ME
    Pharm Res; 2014 Apr; 31(4):837-46. PubMed ID: 24395404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products.
    Wang R; Conner DP; Li BV
    AAPS J; 2017 Mar; 19(2):360-366. PubMed ID: 28004346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of an Optimized Tape Stripping Method for the Bioequivalence Assessment of Topical Acyclovir Creams.
    Nallagundla S; Patnala S; Kanfer I
    AAPS PharmSciTech; 2018 May; 19(4):1567-1573. PubMed ID: 29484615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence of topical generic products. Part 2. Paving the way to a tailored regulatory system.
    Miranda M; Sousa JJ; Veiga F; Cardoso C; Vitorino C
    Eur J Pharm Sci; 2018 Sep; 122():264-272. PubMed ID: 29981406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence determination of topical ketoprofen using a dermatopharmacokinetic approach and excised skin penetration.
    Lodén M; Akerström U; Lindahl K; Berne B
    Int J Pharm; 2004 Oct; 284(1-2):23-30. PubMed ID: 15454293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Clobetasol Propionate Generics Using Simplified In vitro Bioequivalence Method for Topical Drug Products.
    Soares KCC; de Souza WC; de S Texeira L; da Cunha-Filho MSS; Gelfuso GM; Gratieri T
    Curr Drug Deliv; 2018; 15(7):998-1008. PubMed ID: 29165079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles and criteria in the development and optimization of topical therapeutic products.
    Shah VP; Behl CR; Flynn GL; Higuchi WI; Schaefer H
    Skin Pharmacol; 1993; 6(1):72-80. PubMed ID: 8489779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the bioequivalence of topical retinoid products by pharmacodynamic assay.
    Lehman PA; Franz TJ
    Skin Pharmacol Physiol; 2012; 25(5):269-80. PubMed ID: 22847319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vehicle effects in percutaneous absorption.
    Idson B
    Drug Metab Rev; 1983; 14(2):207-22. PubMed ID: 6341025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.